A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
Surosree Ganguli,1 Peter DeLeeuw,2 Sanjaya K Satapathy3 1Division of Internal Medicine, University of Louisville, Louisville, KY 40202, USA; 2Division of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA; 3Division of Hepatology and Sandra Atlas Bass Center for...
Guardado en:
Autores principales: | Ganguli S, DeLeeuw P, Satapathy SK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/acfb6ebad0b44dd59bdcc63f07870f85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Justine Gillard, et al.
Publicado: (2022) -
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
por: Philippe Garteiser, et al.
Publicado: (2021) -
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease
por: Bradford V, et al.
Publicado: (2013) -
PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation
por: Barbara Becattini, et al.
Publicado: (2021) -
Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021)